John Newman
Analyst
Canaccord
Equibles does not estimate personal net worth.
About John Newman
John Newman is recorded as Analyst at Canaccord. John Newman has spoken on 1 earnings call across 1 company, most recently for Allogene Therapeutics, Inc. on August 12, 2026. The companies whose calls John Newman spoke on are classified in the Healthcare sector.
John Newman on recent calls
“And Zach, congratulations on the new role. I guess I jumped in late. I hope this hasn't already been asked, but I'm interested in the competitive landscape as it continues to evolve and how you guys are kind of thinking about things and managing it.”
Affiliation history
-
Canaccord
Analyst
Transcript header (unverified)
Current